Impax Labs, Tower Holdings settle with FTC over merger
MLex Summary: Pharmaceutical companies Impax Laboratories and Tower Holdings have reached a settlement agreement with the US Federal Trade Commission resolving charges that their proposed merger would likely be anticompetitive. Under the settlement, Impax Laboratories...To view the full article, register now.
Already a subscriber? Click here to view full article